Dasatinib

Product NDC
82009-194
Requested package NDC
82009-194-60
11-digit product format
820090194
Labeler code
82009
Product ID
82009-194_669a5206-88e3-1014-a561-aa33f2b7b3a7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dasatinib
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Quallent Pharmaceuticals Health LLC
Application
ANDA217217
Marketing category
ANDA
Marketing start
2026-11-02
Substance
DASATINIB
Active strength
70 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217217-001DASATINIBDASATINIB20MGTABLET / ORALAB2025-03-03
A217217-002DASATINIBDASATINIB50MGTABLET / ORALAB2025-03-03
A217217-003DASATINIBDASATINIB70MGTABLET / ORALAB2025-03-03
A217217-004DASATINIBDASATINIB80MGTABLET / ORALAB2025-03-03
A217217-005DASATINIBDASATINIB100MGTABLET / ORALAB2025-03-03
A217217-006DASATINIBDASATINIB140MGTABLET / ORALAB2025-03-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-productTE code
A217217-001AB
A217217-002AB
A217217-003AB
A217217-004AB
A217217-005AB
A217217-006AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 54 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A217217-001DASATINIB20MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-002DASATINIB50MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-003DASATINIB70MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-004DASATINIB80MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-005DASATINIB100MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-006DASATINIB140MGTABLET / ORALAB2025-03-03d4dbc9d85df4…
2026-10-15 13:18:302026-09A217217-001DASATINIB20MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-10-15 13:18:302026-09A217217-002DASATINIB50MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-10-15 13:18:302026-09A217217-003DASATINIB70MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-10-15 13:18:302026-09A217217-004DASATINIB80MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-10-15 13:18:302026-09A217217-005DASATINIB100MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-10-15 13:18:302026-09A217217-006DASATINIB140MGTABLET / ORALAB2025-03-03c2088c7a36db…
2026-09-14 22:38:342026-08A217217-001DASATINIB20MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-09-14 22:38:342026-08A217217-002DASATINIB50MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-09-14 22:38:342026-08A217217-003DASATINIB70MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-09-14 22:38:342026-08A217217-004DASATINIB80MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-09-14 22:38:342026-08A217217-005DASATINIB100MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-09-14 22:38:342026-08A217217-006DASATINIB140MGTABLET / ORALAB2025-03-0384e616aacf4f…
2026-08-18 06:07:402026-07A217217-001DASATINIB20MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-002DASATINIB50MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-003DASATINIB70MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-004DASATINIB80MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-005DASATINIB100MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-006DASATINIB140MGTABLET / ORALAB2025-03-03caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217217-001DASATINIB20MGTABLET / ORALAB2025-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-002DASATINIB50MGTABLET / ORALAB2025-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-003DASATINIB70MGTABLET / ORALAB2025-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-004DASATINIB80MGTABLET / ORALAB2025-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-005DASATINIB100MGTABLET / ORALAB2025-03-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-006DASATINIB140MGTABLET / ORALAB2025-03-03011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-001DASATINIB20MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-002DASATINIB50MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-003DASATINIB70MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-004DASATINIB80MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-005DASATINIB100MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-006DASATINIB140MGTABLET / ORALAB2025-03-0331067a03dcf5…
2025-08-23 18:47 UTC2025-08A217217-001DASATINIB20MGTABLET / ORALAB2025-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-002DASATINIB50MGTABLET / ORALAB2025-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-003DASATINIB70MGTABLET / ORALAB2025-03-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-004DASATINIB80MGTABLET / ORALAB2025-03-036a471c1ec25d…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 54 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A217217-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-003AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-004AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-005AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A217217-006AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A217217-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A217217-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A217217-003AB1c2088c7a36db…
2026-10-15 13:18:302026-09A217217-004AB1c2088c7a36db…
2026-10-15 13:18:302026-09A217217-005AB1c2088c7a36db…
2026-10-15 13:18:302026-09A217217-006AB1c2088c7a36db…
2026-09-14 22:38:342026-08A217217-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A217217-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A217217-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A217217-004AB184e616aacf4f…
2026-09-14 22:38:342026-08A217217-005AB184e616aacf4f…
2026-09-14 22:38:342026-08A217217-006AB184e616aacf4f…
2026-08-18 06:07:402026-07A217217-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-004AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-005AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A217217-006AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217217-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-004AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-005AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217217-006AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-004AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-005AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217217-006AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A217217-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217217-004AB16a471c1ec25d…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Dasatinib
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DASATINIB70 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
RBZ1571X5HInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
643105Internal RxNorm lookup
643107Internal RxNorm lookup
643109Internal RxNorm lookup
799047Internal RxNorm lookup
1045402Internal RxNorm lookup
1045406Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4582bf1e-d0c4-88ec-f76c-4670bd7b14adAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DasatinibDASATINIBBluePoint Laboratories02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e42026-03-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217217
application number: ANDA217217
DasatinibDASATINIBQuallent Pharmaceuticals Health LLC4582bf1e-d0c4-88ec-f76c-4670bd7b14ad2026-02-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217217
application number: ANDA217217
ndc (package): 82009-194-60
ndc (product): 82009-194
ndc11 (package): 82009019460
DasatinibDASATINIBBiocon Pharma Inc.76e1833c-e105-5a3d-0f01-1330d8cc7ae12025-02-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217217
application number: ANDA217217

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
82009-194-608200901946060 TABLET, FILM COATED in 1 BOTTLE (82009-194-60) 2026-11-02NoNoCurrent